AUSTRALIA
Australia | AI governance reform moves forward with Voluntary AI Safety Standard & Mandatory Guardrails for High-risk Settings consultation
Recognising that Australia’s existing laws and governance measures do not adequately address the risks presented by AI, the Australian Government advanced two key actions arising from its interim response...
Recognising that Australia’s existing laws and governance measures do not adequately address the risks presented by AI, the Australian...
Read More
AUSTRALIA
Privacy Act legislation overhaul expected this month
A review of Australia’s Privacy Act 1988 (Cth) (Privacy Act) has been ongoing since 2020, and has produced 116 proposed reforms. The expected legislative changes will have implications for...
A review of Australia’s Privacy Act 1988 (Cth) (Privacy Act) has been ongoing since 2020, and has produced 116...
Read More
AUSTRALIA
Protecting your brand from counterfeits
In January 2024, the EU Intellectual Property Office (EUIPO) released a robust study to assess the economic impact of counterfeiting in sales and employment in the clothing (including footwear),...
In January 2024, the EU Intellectual Property Office (EUIPO) released a robust study to assess the economic impact of...
Read More
AUSTRALIA
Navigating the Waves of Greenwashing | Implications for trade mark owners
In the current global landscape, environmental awareness has become a pivotal aspect of consumer decision-making, with many brands eager to market their sustainability credentials. While for some brands this...
In the current global landscape, environmental awareness has become a pivotal aspect of consumer decision-making, with many brands eager...
Read More
AUSTRALIA
Infringement of second medical use claims | Federal Court decision adds guidance
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known substances arise frequently. In this article, we discuss the recent...
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known...
Read More
AUSTRALIA
Recognition in Best Lawyers in 2025
Updated 30 May 2024 Spruson & Ferguson Lawyers is proud to be recognised in the inaugural Best Law Firms - Australia 2025 awards. This is alongside the continued recognition of...
Updated 30 May 2024 Spruson & Ferguson Lawyers is proud to be recognised in the inaugural Best Law Firms -...
Read More
AUSTRALIA
The 2023 Pharmaceutical Patent Review
Welcome to Spruson & Ferguson’s wrap-up of the most notable developments in pharmaceutical patent law in Australia in 2023. The past year saw a number of important Federal Court...
Welcome to Spruson & Ferguson’s wrap-up of the most notable developments in pharmaceutical patent law in Australia in 2023....
Read More
AUSTRALIA
No pay day for Commonwealth in Sanofi pharmaceutical damages claim
Background In the keenly awaited judgment in Commonwealth of Australia v Sanofi (formerly Sanofi-Aventis)  FCAFC 97, the Full Court of the Federal Court of Australia has upheld the trial judge’s decision that...
Background In the keenly awaited judgment in Commonwealth of Australia v Sanofi (formerly Sanofi-Aventis)  FCAFC 97, the Full Court of the Federal...
Read More
AUSTRALIA
To boil, or not to boil, that is the (infringement) question
A recent decision (Calix Limited v Grenof Pty Ltd) from the Federal Court of Australia provides a cautionary tale to patent applicants and patent attorneys regarding the complexities in...
A recent decision (Calix Limited v Grenof Pty Ltd) from the Federal Court of Australia provides a cautionary tale...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe